Skip to content

Clinical trials

Withdrawn Rhabdomyosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Status: Withdrawn Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20131
20141
20162
20181
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brown University2
Children's National Research Institute1
Children's Oncology Group1
Eli Lilly and Company1
M.D. Anderson Cancer Center1
Penn State University1
St. Jude Children's Research Hospital1
Theodore Laetsch1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma10
Osteosarcoma6
Sarcoma4
Neuroblastoma3
Sarcoma, Ewing3
Bone Neoplasms2
Dermatofibrosarcoma2
Hemangiosarcoma2
Histiocytoma, Malignant Fibrous2
Leiomyosarcoma2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.